Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study - PubMed (original) (raw)
. 2013 Sep;136(Pt 9):2707-16.
doi: 10.1093/brain/awt206.
Tuomo Polvikoski, Miia Kivipelto, Maarit Tanskanen, Liisa Myllykangas, Timo Erkinjuntti, Mira Mäkelä, Minna Oinas, Anders Paetau, Philip Scheltens, Elizabeth C W van Straaten, Raimo Sulkava, Alina Solomon
Affiliations
- PMID: 23983028
- PMCID: PMC3754457
- DOI: 10.1093/brain/awt206
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
Babak Hooshmand et al. Brain. 2013 Sep.
Abstract
Elevated plasma total homocysteine is associated with increased risk of dementia/Alzheimer's disease, but underlying pathophysiological mechanisms are not fully understood. This study investigated possible links between baseline homocysteine, and post-mortem neuropathological and magnetic resonance imaging findings up to 10 years later in the Vantaa 85+ population including people aged ≥85 years. Two hundred and sixty-five individuals had homocysteine and autopsy data, of which 103 had post-mortem brain magnetic resonance imaging scans. Methenamine silver staining was used for amyloid-β and modified Bielschowsky method for neurofibrillary tangles and neuritic plaques. Macroscopic infarcts were identified from cerebral hemispheres, brainstem and cerebellum slices. Standardized methods were used to determine microscopic infarcts, cerebral amyoloid angiopathy, and α-synuclein pathology. Magnetic resonance imaging was used for visual ratings of the degree of medial temporal lobe atrophy, and periventricular and deep white matter hyperintensities. Elevated baseline homocysteine was associated with increased neurofibrillary tangles count at the time of death: for the highest homocysteine quartile, odds ratio (95% confidence interval) was 2.60 (1.28-5.28). The association was observed particularly in people with dementia, in the presence of cerebral infarcts, and with longer time between the baseline homocysteine assessment and death. Also, elevated homocysteine tended to relate to amyloid-β accumulation, but this was seen only with longer baseline-death interval: odds ratio (95% confidence interval) was 2.52 (0.88-7.19) for the highest homocysteine quartile. On post-mortem magnetic resonance imaging, for the highest homocysteine quartile odds ratio (95% confidence interval) was 3.78 (1.12-12.79) for more severe medial temporal atrophy and 4.69 (1.14-19.33) for more severe periventricular white matter hyperintensities. All associations were independent of several potential confounders, including common vascular risk factors. No relationships between homocysteine and cerebral macro- or microinfarcts, cerebral amyoloid angiopathy or α-synuclein pathology were detected. These results suggest that elevated homocysteine in adults aged ≥85 years may contribute to increased Alzheimer-type pathology, particularly neurofibrillary tangles burden. This effect seems to be more pronounced in the presence of cerebrovascular pathology. Randomized controlled trials are needed to determine the impact of homocysteine-lowering treatments on dementia-related pathology.
Keywords: Alzheimer pathology; Alzheimer’s disease; cerebrovascular pathology; elderly; homocysteine.
Similar articles
- The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
Liu Y, Chan DK, Crawford JD, Sachdev PS, Braidy N. Liu Y, et al. Curr Alzheimer Res. 2020;17(13):1167-1176. doi: 10.2174/1567205018666210212160902. Curr Alzheimer Res. 2020. PMID: 33583381 Free PMC article. - CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study.
Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Mäkelä M, Oinas M, Paetau A, Solomon A. Hooshmand B, et al. J Intern Med. 2018 Jun;283(6):597-603. doi: 10.1111/joim.12736. Epub 2018 Mar 14. J Intern Med. 2018. PMID: 29411449 - Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.
Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinistö L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN. Polvikoski TM, et al. Neurology. 2010 Dec 7;75(23):2071-8. doi: 10.1212/WNL.0b013e318200d6f9. Epub 2010 Nov 3. Neurology. 2010. PMID: 21048201 Free PMC article. - Vascular dementia: atherosclerosis, cognition and Alzheimer's disease.
OBrien RJ. OBrien RJ. Curr Alzheimer Res. 2011 Jun;8(4):341-4. doi: 10.2174/156720511795745267. Curr Alzheimer Res. 2011. PMID: 21557721 Review.
Cited by
- Cortical lobar volume reductions associated with homocysteine-related subcortical brain atrophy and poorer cognition in healthy aging.
Song H, Bharadwaj PK, Raichlen DA, Habeck CG, Grilli MD, Huentelman MJ, Hishaw GA, Trouard TP, Alexander GE. Song H, et al. Front Aging Neurosci. 2024 Aug 7;16:1406394. doi: 10.3389/fnagi.2024.1406394. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39170895 Free PMC article. - Association of Long-term Exposure to Air Pollution and Dementia Risk: The Role of Homocysteine, Methionine, and Cardiovascular Burden.
Grande G, Hooshmand B, Vetrano DL, Smith DA, Refsum H, Fratiglioni L, Ljungman P, Wu J, Bellavia A, Eneroth K, Bellander T, Rizzuto D. Grande G, et al. Neurology. 2023 Sep 19;101(12):e1231-e1240. doi: 10.1212/WNL.0000000000207656. Epub 2023 Jul 13. Neurology. 2023. PMID: 37442622 Free PMC article. - Longitudinal study of Alzheimer's disease biomarkers, allostatic load, and cognition among memory clinic patients.
Adedeji DO, Holleman J, Juster RP, Udeh-Momoh CT, Kåreholt I, Hagman G, Aspö M, Adagunodo S, Håkansson K, Kivipelto M, Solomon A, Sindi S. Adedeji DO, et al. Brain Behav Immun Health. 2023 Feb 1;28:100592. doi: 10.1016/j.bbih.2023.100592. eCollection 2023 Mar. Brain Behav Immun Health. 2023. PMID: 36820052 Free PMC article. - Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue.
Weekman EM, Winder Z, Rogers CB, Abner EL, Sudduth TL, Patel E, Dugan AJ, Fister SX, Wasek B, Nelson PT, Jicha GA, Bottiglieri T, Fardo DW, Wilcock DM. Weekman EM, et al. Alzheimers Dement (N Y). 2022 Dec 8;8(1):e12368. doi: 10.1002/trc2.12368. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 36514441 Free PMC article. - Association of homocysteine-related subcortical brain atrophy with white matter lesion volume and cognition in healthy aging.
Song H, Bharadwaj PK, Raichlen DA, Habeck CG, Huentelman MJ, Hishaw GA, Trouard TP, Alexander GE. Song H, et al. Neurobiol Aging. 2023 Jan;121:129-138. doi: 10.1016/j.neurobiolaging.2022.10.011. Epub 2022 Oct 29. Neurobiol Aging. 2023. PMID: 36436304 Free PMC article.
References
- Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology. 2010;75:1195–202. - PubMed
- Alexopoulos P, Gunther F, Popp J, Jessen F, Peters O, Wolf S, et al. Plasma homocysteine and cerebrospinal fluid neurodegeneration biomarkers in mild cognitive impairment and dementia. J Am Geriatr Soc. 2009;57:737–9. - PubMed
- Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89:693S–6. - PubMed
- Allsop D, Haga SI, Haga C, Ikeda SI, Mann DM, Ishii T. Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol. 1989;15:531–42. - PubMed
- Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2000;15:911–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical